Cadila, Korea co ink pact over hepatitis-B shot
Cadila Healthcare has entered into an agreement with Korea Green Cross Corporation to manufacture and market recombinant hepatitis-B vaccine in India. It will also be launching an anti-rabies vaccine
Cadila Healthcare has entered into an agreement with Korea Green Cross Corporation to manufacture and market recombinant hepatitis-B vaccine in India. It will also be launching an anti-rabies vaccine